IL6 and cancer: Among the wide array of positive effects on body organs (e.g., bone, brain, liver, skeletal muscle, adipose tissue, etc.), preclinical and translational in vitro studies have shown the potential role of myokines (e.g., IL-6, OSM, decorin) to suppress cancer cell growth in different cancer cell lines [17–20].